Page 1522 - Small Animal Internal Medicine, 6th Edition
P. 1522

1494   PART XIV   Infectious Diseases


            treatment periods may be required. The only way to deter-  shared by cats with scalding water and detergent inactivates
            mine if an FIV-seropositive cat with a concurrent infection   the virus. Cats with potential exposure from fighting should
  VetBooks.ir  has a poor prognosis is to treat the concurrent infection.  be retested 60 days after the exposure (Goldkamp et al.,
              A number of antilentiviral drugs may be effective for the
                                                                 2008). Cats that are FIV-infected should be housed indoors
            treatment of FIV-infected cats, but controlled studies are
                                                                 ment to the virus and to lessen the affected animal’s chance
            largely lacking (Hartmann et al., 2015;  Mohammad and   at all times to avoid exposing FIV-naïve cats in the environ-
            Bienzle, 2012). Administration of interferons has shown   of acquiring opportunistic infections. Kittens queened by
            clinical benefit in some studies. Oral administration of   FIV-infected cats should not be allowed to nurse to avoid
            10 IU/kg of human interferon-α led to improved clinical   transmission by ingestion of milk; they should be shown to
            signs and prolonged survival compared with a placebo-  be serologically negative at 6 months of age to document
            treated control group in one study (Pedretti et al., 2006). In   failure of lactogenic or transplacental transmission before
            another study, feline recombinant interferon was adminis-  being sold or adopted. In one study, FIV-positive cats housed
            tered at 10  U/kg/day subcutaneously (SC) for 5 days in three   in groups of ≤ 2 cats had better long-term outcomes than
                    6
            series (starting on days 0, 14, and 60) and was shown to   FIV-positive cats housed in large groups (Beczkowski et al.,
            improve clinical signs early in the study and prolong survival   2015). A killed vaccine containing immunogens from two
            in treated cats (de Mari et al., 2004). In another study with   FIV isolates is licensed for use in some countries. However,
            recombinant feline interferon omega, neither a subcutane-  the efficacy of the vaccine is in question (Westman et al.,
            ous protocol nor an oral protocol lessened FIV viremia, but   2016b).
            IL-6 was decreased (Leal et al., 2015). The use of feline inter-  HIV and FIV are morphologically similar but antigeni-
            feron and potential immunomodulatory effects on FIV   cally distinct. Antibodies against FIV have not been docu-
            infection have been reviewed (Leal and Gil, 2016). Admin-  mented in the serum of human beings, even after accidental
            istration of bovine lactoferrin by mouth was beneficial in the   exposure to virus-containing material (Butera et al., 2000;
            treatment of intractable stomatitis in FIV-seropositive cats   Dickerson et al., 2012). Cats with FIV infection resulting in
            (Sato et al., 1996). Removal of all premolar and molar teeth   immunodeficiency may be more likely to spread other zoo-
            has also been effective for treatment of intractable stomatitis   notic agents into the human environment; clinically ill, FIV-
            in some FIV-seropositive cats.                       seropositive cats should therefore undergo a thorough
              Other substances like the reverse transcriptase inhibi-  diagnostic evaluation (see Chapter 99).
            tor azidothymidine (AZT), melittin, and phosphonate
            9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine,
            9-(2-phosphonylmethoxyethyl) adenine, or plerixafor have   FELINE LEUKEMIA VIRUS
            had mixed success in the treatment of FIV and are generally
            not used clinically in the United States for management of   Etiology and Epidemiology
            FIV  cats.  Human  recombinant  erythropoietin  administra-  FeLV is a single-strand RNA virus in the family Retroviridae,
            tion increased red blood cell and white blood cell counts,   subfamily Oncovirinae. The virus produces reverse tran-
            did not increase viral load, and had no measurable adverse   scriptase, which catalyzes the reaction, resulting in the for-
            clinical effects in FIV-infected cats compared with placebo   mation of a DNA copy (provirus) of FeLV viral RNA in the
            (Arai et al., 2000) and could be considered for management   cytoplasm of infected cells; the provirus is inserted into the
            of anemia in FIV-infected cats. In contrast, although admin-  host cell genome. On subsequent host cell divisions the pro-
            istration of human recombinant granulocyte-monocyte   virus serves as a template for new virus particles formed in
            colony-stimulating  factor  (GM-CSF)  to  FIV-infected  cats   the cytoplasm and is released across the cell membrane by
            increased white blood cell counts in some treated cats, it   budding. FeLV is composed of several core and envelope
            also induced fever, anti–GM-CSF antibodies, and increased   proteins. Envelope protein p15e induces immunosuppres-
            viral load; GM-CSF therefore appears to be contraindicated   sion. Core protein p27 is present in the cytoplasm of infected
            for this syndrome. Cats with FIV and hospitalized cats had   cells, peripheral blood, saliva, and tears of infected cats;
            lower serum 25-hydroxyvitamin D [25(OH)D] concentra-  detection of p27 is the basis of most FeLV antigen tests. The
            tions than healthy cats in one study (Titmarsh et al., 2015).   envelope glycoprotein 70 (gp70) contains the subgroup anti-
            Whether supplementation will have clinical benefit in the   gens A, B, or C, which are associated with the infectivity,
            management if FIV infections remains to be proven.   virulence,  and disease  caused by  individual  strains  of  the
                                                                 virus. Neutralizing antibodies are produced by some cats
            Prevention and Zoonotic Aspects                      after exposure to gp70. Antibodies against feline oncornavirus-
            Housing cats indoors to avoid fighting and testing new cats   associated cell membrane antigen (FOCMA) are formed by
            before introduction to an FIV-seronegative, multiple-cat   some cats but are generally not used clinically.
            household will prevent most cases of FIV. Transmission by   The principal route of infection by FeLV is prolonged
            fomites is unusual because the virus is not easily transmitted   contact with infected cat saliva and nasal secretions; groom-
            by casual contact, is susceptible to most routine disinfec-  ing or sharing common water or food sources effectively
            tants, and dies when out of the host after minutes to hours,   results in infection. Because the organism does not survive
            especially when dried. Cleaning litter boxes and dishes   in the environment, feces, urine, fomite, and aerosol
   1517   1518   1519   1520   1521   1522   1523   1524   1525   1526   1527